A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Genmab
Radiopharm Theranostics, Ltd
Filamon LTD
Eisai Inc.
PMV Pharmaceuticals, Inc
NeoImmuneTech
Qilu Pharmaceutical Co., Ltd.
Tubulis GmbH
AstraZeneca
Genmab
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Essen Biotech
Essen Biotech
Revolution Medicines, Inc.
AstraZeneca
Lumicell, Inc.
Perspective Therapeutics
Second Life Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
BicycleTx Limited
Shasqi, Inc.
Alaunos Therapeutics
Incyte Corporation
Hadassah Medical Organization
Hadassah Medical Organization
Eli Lilly and Company
LigaChem Biosciences, Inc.
Shanghai Escugen Biotechnology Co., Ltd
TCR2 Therapeutics
TCR2 Therapeutics
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Incyte Corporation
Cancer Research UK
University of California, Irvine
Medicenna Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
OncoC4, Inc.
Numab Therapeutics AG
NextCure, Inc.
National Institutes of Health Clinical Center (CC)
Portage Biotech
Heronova Pharmaceuticals
Evopoint Biosciences Inc.